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Abstract
Background: In our hospital a fast-track setting including a multimodal pain protocol is used for total hip arthroplasty
(THA). Despite this multimodal pain protocol there is still a large range in reported postoperative pain between patients,
which hinders mobilization and rehabilitation postoperatively. The goal of this study was to identify which patient-specific
and surgical characteristics influence postoperative pain after THA in a fast-track setting.
Methods: All 74 patients with osteoarthritis of the hip who underwent primary THA procedure by anterior supine
intermuscular approach between November 2012 and January 2014 were included in this prospective cohort study.
The protocol for pain medication was standardized.
Postoperative pain determined with the Numeric Rating Score was collected at 17 standardized moments. Linear
mixed models were used to examine potential patient-specific and surgical factors associated with increased
postoperative pain.
Results: Pain patterns differed substantially across individuals. Adjusted for other variables in the model, preoperative
use of pain medication (regression coefficient 0.78 (95% CI 0.28–1.26); p = 0.005) and preoperative neuropathic pain
scored by DN4 (regression coefficient 0.68 (95% CI 0.15–1.20); p = 0.02) were the only factors significantly associated
with higher postoperative pain scores.
Conclusions: The knowledge of which factors are associated with higher postoperative pain scores after THA in a fast-track
setting may help optimizing perioperative postoperative pain management and preoperative education of these patients.
Trial registration: The study was retrospectively registered in the ISRCTN registry under identifier ISRCTN15422220
(date of registration: July 25, 2017).
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Background
Total hip arthroplasty (THA) is associated with consider-
able postoperative pain [1]. Almost all pain after surgery
arises as a result of tissue damage at the surgical site [2].
This postoperative pain hinders early mobilization and
rehabilitation with subsequent consequences on mobility
and overall recovery [3]. In the last few years fast-track pro-
tocols have been introduced worldwide for elective primary
THA. These are partly based on pain management proto-
cols and include a rigorous perioperative pain management
program, which allow for an optimized perioperative period
[4, 5]. In 2009, a fast-track protocol including a multimodal
pain protocol was successfully introduced in our teaching
hospital [6]. The multimodal pain protocol, developed
to reduce acute postoperative pain to enable quick
mobilization and rehabilitation included paracetamol, cele-
coxib, gabapentine, dexamethasone and esketamine [7–12].
Furthermore, we use the anterior supine intermuscular
(ASI) approach for THA procedures in our hospital. Since
this approach uses both an intermuscular and internervous
plane and causes less surgical trauma, lower postoperative
pain scores and less pain medication consumption have
been described for this approach [13–18]. Despite the
introduction of a multimodal pain protocol and use of the
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ASI approach, there is still a large range in reported postop-
erative pain between patients.
Previous studies have shown that specific patient- and
provider characteristics could influence postoperative
pain [19–27]. Only one of these studies reported solely
on postoperative pain after primary THA [21]. None of
these studies were performed in a fast-track setting and
no multimodal pain protocols developed to reduce acute
postoperative pain were included in these studies.
The proper identification of patients who are at risk to
experience more postoperative pain directly after primary
THA might provide details for further optimization of
postoperative pain management and preoperative educa-
tion of these patients. Therefore, the goal of this study was
to identify which patient-specific and surgical characteris-
tics influence postoperative pain after primary THA by
ASI approach in a fast-track setting including a multi-
modal pain protocol.
Methods
All 74 patients with osteoarthritis (72 patients with pri-
mary osteoarthritis, 2 patients with secondary osteoarth-
ritis) of the hip who underwent primary THA procedure
by ASI approach between November 2012 and January
2014 were included in this prospective cohort study. All
procedures were performed in a fast-track setting, by
one experienced orthopedic hip surgeon (SBV). Patients
with neurological conditions which potentially influence
pain perception; American Society of Anaesthesiologists
(ASA) classification III/IV; medical contra-indication for
spinal anesthesia; cardiovascular impairment in the
present or past; known allergy against any element of
the medication that is given for the multimodal pain
protocol; abuse of alcohol or drugs; rheumatoid arthritis;
BMI > 40 kg/m2; and patients with cognitive impairment
were excluded.
As part of the fast-track setting, all patients joined a
patient education program prior to surgery. All patients
received spinal anesthesia with a low dose of bupivacaine
(6–8 mg intrathecally). Propofol was administered for
sedation and to allow a single shot of esketamine. The
multimodal protocol for perioperative pain medication
was standardized (Table 1). Before discharge, adequate
pain relief had to be achieved by oral pain medication:
the Numeric Rating Scale (NRS) for pain had to be
below 3 in rest and below 5 during mobilization (NRS; 0
to 10, best to worst).
Postoperative pain determined with the NRS was col-
lected at 17 standardized moments, from 1 h after sur-
gery until the afternoon of the second day after surgery
(Fig. 1). The study protocol was approved by our local
Ethics Committee (2012–000989-37/NL39970.098.12).
The study was retrospectively registered in the ISRCTN
registry under identifier ISRCTN15422220 (date of regis-
tration: July 25, 2017).
Potential factors associated with increased postopera-
tive pain (gender; ASA classification; age; BMI; diabetes
mellitus (DM); surgery time; incision length; living
situation; preoperative pain determined with the NRS,
preoperative use of pain medication; use of antidepres-
sants; as well as preoperative scores of the neuropathic
pain diagnostic questionnaire (DN4), and Amsterdam
Preoperative Anxiety and Information Scale (APAIS) for
anxiety and information requirements) were examined
with univariable linear mixed models for repeated mea-
sures. Decision to include these variables was based on
guidance from directed acyclic graphs [28]. Based on the
criteria in the original article about the APAIS by
Moerman and others [29], the APAIS anxiety scale was
dichotomized (4–10: no, 11–20: yes), and the APAIS
Table 1 The standardized multimodal protocol for perioperative
pain medication
Timing Medication
2 h before surgery Paracetamol (acetaminophen)
1000 mg per os.
Celecoxib (Celebrex®) a 400 mg
per os.
Gabapentin 600 mg per os.
Just before surgery Dexamethasone 0.15 mg/kg iv. b
Esketamine 15 mg iv.
4 h after surgery Paracetamol (acetaminophen)
1000 mg per os.
8 h after surgery Paracetamol (acetaminophen)
1000 mg per os.
Gabapentin 300 mg per os.
Before the night Tramadol 100 mg supp.
Day 1 Paracetamol (acetaminophen)
1000 mg per os 4 times a day.
Celecoxib (Celebrex®) a 200 mg
per os in the morning.
Gabapentin 300 mg per os in the
morning.
After day 1 Paracetamol (acetaminophen)
1000 mg per os 4 times a day
(with a maximum of 2 weeks).
Celecoxib (Celebrex®) a 200 mg
per os in the morning (until 2 weeks
after surgery).
Rescue medication Celecoxib (Celebrex®) a 200 mg per
os extra after the first night
Piritramid (Dipidolor®) 10 mg im, which
could be repeated every 4 h.
The standardized multimodal protocol for perioperative pain medication was
determined based on literature [7–12]
aIn combination with celecoxib (Celebrex®) all patients will receive omeprazol
20 mg per os once a day as prophylaxis. When the patient was already using a
proton pomp inhibitor before admittance no omeprazol was administered
bDexamethasone solution in 50cm3 saline is administered slowly to avoid
adverse side effects like severe perianal pain
den Hartog et al. BMC Musculoskeletal Disorders  (2017) 18:363 Page 2 of 7
need-for-information scale was divided into three cat-
egories (2–4: no or little, 5–7: average, and 8–10: high).
The DN4 questionnaire score was dichotomized (1–3
unlikely; 4–7 likely) [30, 31].
Factors that were associated with the outcome in uni-
variable analyses (p-values <0.20) were included in mul-
tivariable analyses. In the multivariable analyses p-values
less than 0.05 were considered significant. Missing data
were assumed to be missing at random. Regression coef-
ficients are presented with their 95% confidence inter-
vals. The statistical analyses were performed using R
version 3.1.2 with package ‘nlme’ [32, 33].
Results
Mean age of all patients was 67.1 year (range 42.7–84.6)
and mean BMI was 27.1 kg/m2 (range 20.1–38.9). Mean
LOS was 1.8 nights (range 1–7). Most patients lived to-
gether with cohabitants (n = 58; 78.4%) and were dis-
charged to their own home (n = 72; 97.3%). Patient
characteristics are listed in Table 2.
Seventy-three patients received an uncemented pros-
theses (Taperloc® femoral prosthesis and an Universal®
cup, both Biomet, Warsaw, In, USA), one patient re-
ceived a cemented prosthesis because of inferior bone
quality due to severe osteoporosis. (Exceed Muller® cup
and a Taperloc® femoral prosthesis, both Biomet,
Warsaw, In, USA).
Pain patterns differed substantially across individuals.
Moreover, pain varied across the standardized moments
(Table 3). Adjusted for the other factors in the model,
preoperative use of pain medication (regression coeffi-
cient 0.78 (95% CI 0.28–1.26); p = 0.005) and preopera-
tive neuropathic pain scored by DN4 (regression
coefficient 0.68 (95% CI 0.15–1.20); p = 0.02) were the
only factors that were significantly associated with
higher postoperative pain scores (Table 4).
Discussion
The aim of this study was to identify which patient-
specific and surgical characteristics influence postopera-
tive pain after primary THA by ASI approach in a fast-
track setting, using a multimodal pain protocol which
was developed to reduce acute postoperative pain to en-
able quick mobilization and rehabilitation. The only two
factors associated with increased postoperative pain ad-
justed for the other factors in the model, were preopera-
tive use of pain medication (regression coefficient 0.78
(95% CI 0.28–1.26); p = 0.005) and preoperative neuro-
pathic pain scored by DN4 (regression coefficient 0.68
(95% CI 0.15–1.20); p = 0.02).
In our study, we used a multimodal pain protocol, in-
cluding paracetamol, celecoxib, gabapentin, dexametha-
sone and esketamine [7–12]. This pain protocol is part
Fig. 1 Overview of pre- and postoperative pain measurements.
Postoperative pain determined with the NRS was collected at 17
standardised moments, from 1 h after surgery until the afternoon of
the second day after surgery
Table 2 Patient characteristics for the total group of 74 patients
undergoing primary total hip arthroplasty
Total n (%)
n = 74
Age (year) 67.1 (42.7–84.6) a
BMI (kg/m2) 27.1 (20.1–38.9) a
Gender male 36 (48.6%)
ASA classification ASA2 47 (63.5%)
Surgery time (minutes) 79.2 (49–116) a
Diabetes Mellitus 7 (9.5%)
Incision length (cm) 9.97 (7.5–12.0) a
Living situation with cohabitants 58 (78.4%)
Preoperative antidepressants use 4 (5.4%)
Preoperative pain medication use 50 (67.6%)
Preoperative pain (NRS) b 5.26 (0–9) a
DN4 likely 16 (21.6%)
APAIS anxiety yes 15 (23.1%)




bn = 72 patients
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of a fast-track setting and is developed to reduce acute
postoperative pain to enable patients to quickly mobilize
and rehabilitate in an optimized and safe perioperative
period [4, 5]. Mean postoperative pain score determined
with the NRS collected at 17 standardized moments,
varied from 1.51 (range 0.0–8.0) to 2.97 (range 0.0–9.0).
These results demonstrate that the use of our multi-
modal pain protocol enables adequate postoperative pain
relief in which patients are able to mobilize and rehabili-
tate quickly. However, despite this pain protocol, a large
range in reported postoperative pain between patients
still exists, including some outliers with high postopera-
tive pain scores.
Pain has been described to be a sensory and emotional
experience that is influenced by multiple factors [34, 35].
Although several other studies reported on effects of
specific patient- and provider characteristics on postop-
erative pain [19–27], none of these studies were per-
formed in a fast-track setting with a multimodal pain
protocols developed to reduce acute postoperative pain
(and hence enable early mobilization), were included in
these studies. Since no literature reports on the effect of
potential factors associated with increased postoperative
pain in a fast-track setting, our model included various
potential factors that have been described to be associ-
ated with postoperative pain based on a non-fast-track
setting [19–27, 36]. The use of a multimodal pain proto-
col in our study might have influenced the effects of
these characteristics on postoperative pain and could be
a reason for discrepancy between our results and results
of these other studies.
Preoperative use of pain medication provides information
on the preoperative pain levels of patients and has been
shown to be associated with more severe postoperative pain
[26, 27]. Our study supports these findings. In contrast,
Table 3 Pain scores determined with the NRS at the
standardized moments
NRS N mean (range)
Preoperative 72 5.26 (0.0–9.0)
Day of surgery 1 h 69 1.51 (0.0–8.0)
4 h 74 2.97 (0.0–9.0)
Before mobilization 69 2.62 (0.0–6.0)
After mobilization 65 2.93 (0.0–10.0)
8 h 72 2.40 (0.0–8.0)
Day 1 Morning 67 1.63 (0.0–5.0)
Before mobilization 72 1.71 (0.0–7.0)
After mobilization 71 2.25 (0.0–9.0)
Afternoon 60 1.57 (0.0–6.0)
Before mobilization 54 1.26 (0.0–4.0)
After mobilization 54 1.73 (0.0–6.0)
Day 2 Morning 39 2.00 (0.0–7.0)
Before mobilization 41 1.54 (0.0–6.0)
After mobilization 41 1.84 (0.0–4.5)
Afternoon 14 1.82 (0.0–3.0)
Before mobilization 15 1.27 (0.0–3.0)
After mobilization 15 1.93 (0.0–4.0)
Table 4 Regression coefficients with 95% CIs for potential factors associated with increased postoperative pain after THA in a
fast-track setting
Univariable analyses Multivariable analysis
coefficient (95% CI) p-value coefficient (95% CI) p-value
Age 0.006 (−0.02–0.03) 0.66 – –
BMI 0.03 (−0.03–0.09) 0.28 – –
Gender male vs. female −0.31 (−0.79–0.18) 0.22 – –
ASA classification ASA2 vs. ASA1 0.30 (−0.21–0.80) 0.25 – –
Surgery time −0.01 (−0.03–0.0005) 0.06 0.0004 (−0.01–0.01) 0.96
Diabetes Mellitus −0.05 (−0.88–0.78) 0.92 – –
Incision length 0.02 (−0.26–0.31) 0.89 – –
Living situation with cohabitants vs. alone 0.53 (−0.05–1.10) 0.08 0.50 (−0.08–1.07) 0.11
Preoperative antidepressants use yes vs. no 0.66 (−0.39–1.71) 0.22 – –
Preoperative pain medication use yes vs. no 0.68 (0.18–1.18) 0.009 0.78 (0.28–1.26) 0.005
Preoperative pain 0.10 (−0.01–0.21) 0.08 −0.02 (−0.13–0.09) 0.73
DN4 likely vs. unlikely 0.70 (0.13–1.28) 0.02 0.68 (0.15–1.20) 0.02
APAIS anxiety yes vs. no −0.06 (−0.67–0.54) 0.84 – –
APAIS information average vs. no/little −0.02 (−0.61–0.56) 0.93 −0.21 (−0.74–0.31) 0.45
high vs. no/little 0.50 (−0.16–1.15) 0.15 0.45 (−0.12–1.02) 0.15
Factors that were associated with the outcome in univariable analyses (p-values <0.20) were included in a multivariable linear mixed model for repeated
measures. In the multivariable analyses p-values <0.05 were considered significant
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another study on postoperative pain 12 to 24 h after elect-
ive abdominal surgery, demonstrated no effect of preopera-
tive use of pain medication on postoperative pain [23].
Our multimodal protocol for postoperative pain medi-
cation was standardized for all patients. The effect of
this pain protocol might therefore not be sufficient for
single patients who are used to pain medication. On the
other hand, in a study on postoperative pain after thor-
acic surgery a decrease in postoperative pain medication
use for patients who used pain medication preopera-
tively was found [37].
DN4 [30, 31] is a validated questionnaire for neuro-
pathic pain, which was preoperatively scored for all pa-
tients in our study. The differences between neuropathic
pain and non-neuropathic (nociceptive) pain have been
described in literature [30]. Osteoarthritis, the main indi-
cation for THA in our study, causes non-neuropathic
pain [30]. Patients who experience non-neuropathic pain
from osteoarthritis preoperatively, are more likely to
benefit from THA and will experience less pain postop-
eratively. Since preoperative neuropathic pain is not
caused by osteoarthritis of the hip [30], THA will prob-
ably not resolve this neuropathic pain. As a conse-
quence, these patients will be more likely to experience
more postoperative pain after primary THA.
In the present study, none of the other factors were
significantly associated with postoperative pain. All of
these potential factors have been described to be associ-
ated with postoperative pain in non-fast-track setting
studies [19–27, 36]. Contrasting results on the effect of
age on postoperative pain have been reported in
literature, including an association between younger age
and a higher level of postoperative pain [20, 23, 24, 27]
as well as a lack of effect of age on the level of postoper-
ative pain [26, 38].
BMI has been shown to be associated with an
increased inflammatory response [38], which is related
to higher levels of postoperative pain [39], whereas
others demonstrated no effect of BMI on postoperative
pain scores [24, 39, 40]. In our study we excluded pa-
tients with BMI > 40 kg/m2, which might be a reason
for lack of effect of BMI on postoperative pain.
Regarding gender, contrasting results on the effect on
postoperative pain have been reported in literature as
well. These results include both higher postoperative
pain for female patients [24, 27, 38] and no effect of gen-
der on postoperative pain [22, 23, 25, 26].
Higher ASA classification has also been shown to be as-
sociated with increased postoperative pain [23]. However,
in our study we only included patients with ASA classifi-
cation I or II, which might be a reason for lack of effect of
ASA classification on postoperative pain.
An increased incision length results in increased tissue
damage, and might subsequently result in increased
postoperative pain. This relation has been described in
literature [24]. In our study the ASI approach was used.
Since this approach uses both an intermuscular and
internervous plane, less surgical trauma and hence lower
postoperative pain scores and less pain medication con-
sumption have been described [13–18].
Use of antidepressants provides information on
patients’ mental state, which could be predictive for the
patients’ response on pain medication and pain experi-
ence [25]. Moreover, in literature depression symptoms
have been mentioned to be related to higher level of
postoperative pain [23, 38, 41].
Furthermore, we used different validated question-
naires preoperatively for all patients to define preopera-
tive pain and pain characteristics, including the APAIS
[29]. Anxious patients respond differently to anesthesia
and pain than non-anxious patients and therefore
require larger doses of anaesthetics [19, 20, 25, 42, 43].
It has been reported that the anxiety/‘worry’ component
of the APAIS is positively associated with the occurrence
of early postoperative pain, whereas a strong information
seeking behavior reduces the incidence of severe postop-
erative pain [24]. This is in contrast to others who report
that patients who require more information about
impending discomforts preoperatively may sensitize the
individual to the experience [19].
Some potential limitations of our study should be dis-
cussed. First, although only 74 patients were included in
the present study, a strength of the study is that we used
linear mixed models. These do not only model the cor-
relation between repeated measures of the same patient,
they also assess fluctuations in postoperative pain over
time. Second, although others investigated effects of oc-
cupation and/or level of education [19, 23, 40, 41], SF-36
[24], and heart rate and blood pressure [36] on postoper-
ative pain, we were not able to include these variables in
our model, because these variables were not reported in
a consistent way in the patient files. Third, one single
orthopaedic surgeon performed all surgical procedures
which reduces variation in operative technique, however,
could potentially mask systematic faults in surgical tech-
nique or surgical approach. Fourth, the indication of
THA could be questioned in patients who do not need
any preoperative pain medication. In our study, 50 out
of 76 reported to use preoperative pain medication. Na-
tional and international evidence-based guidelines for
hip and knee OA recommend to start with (a combin-
ation of) conservative treatments. Despite the recom-
mendation in guidelines to start with conservative
treatments and only use surgical intervention if a patient
does not respond sufficiently to conservative treatment
options, the use of conservative treatments in daily prac-
tice is suboptimal [44–47]. It has been shown that
conservative treatments were not fully exploited in 81%
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of the patients who were referred to specialized knee/hip
OA outpatient clinics [44]. Even worse, a recent study
showed that only 10% of the patients in orthopaedic
practice received all recommended non-surgical treat-
ments before surgery [48].
A qualitative systematic review of Ip and others [36]
identified factors associated with postoperative pain and
analgesic consumption. Type of surgery was an important
predictive factor for postoperative pain. This suggests that
results of our study are applicable for primary THA.
Furthermore, this could be another reason for the discrep-
ancy between different studies describing postoperative
pain after different types of surgery, besides differences in
the pain protocol used.
Conclusion
Only preoperative use of pain medication and preopera-
tive neuropathic pain were associated with increased
postoperative pain after primary THA in a fast-track set-
ting, including a multimodal pain protocol which was
developed to reduce acute postoperative pain to enable
quick mobilization and rehabilitation. This knowledge
provides further details for optimization of postoperative
pain management and preoperative patient education.
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